Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition
Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition kdunleavy Fri, 03/18/2022 – 18:13 Source link